Have Insiders Sold Utah Medical Products Shares Recently? \

Sep 18, 2023

Stock Analysis

We note that the Utah Medical Products, Inc. (NASDAQ:UTMD) Independent Director, Paul Richins, recently sold US$65k worth of stock for US$93.47 per share. However we note that the sale only shrunk their holding by 3.2%.

View our latest analysis for Utah Medical Products

In fact, the recent sale by Paul Richins was the biggest sale of Utah Medical Products shares made by an insider individual in the last twelve months, according to our records. That means that an insider was selling shares at around the current price of US$92.74. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

Paul Richins divested 1.35k shares over the last 12 months at an average price of US$92.14. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders have been buying them).

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. It appears that Utah Medical Products insiders own 6.5% of the company, worth about US$22m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

An insider hasn't bought Utah Medical Products stock in the last three months, but there was some selling. And even if we look at the last year, we didn't see any purchases. On the plus side, Utah Medical Products makes money, and is growing profits. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. So we'd only buy after careful consideration. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Utah Medical Products. For example - Utah Medical Products has 1 warning sign we think you should be aware of.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

What are the risks and opportunities for Utah Medical Products?

NasdaqGS:UTMD

Utah Medical Products

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry.Show more

Rewards

Trading at 29% below our estimate of its fair value

Earnings grew by 12.1% over the past year

Risks

Significant insider selling over the past 3 months

Share Price

Market Cap

1Y Return

Further research onUtah Medical Products

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry.

Flawless balance sheet with solid track record and pays a dividend.